Us Bancorp \De\ Axsome Therapeutics, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 133,126 shares of AXSM stock, worth $12.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

133,126

Previous 132,705 0.32%

Holding current value

$12.1 Million

Previous $10.7 Million 11.97%

% of portfolio

0.02%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$78.93 - $95.84 $33,229 - $40,348	421 Added 0.32%	133,126 $12 Million
Q2 2024 Aug 06, 2024	SELL	$65.72 - $80.5 $52,576 - $64,400	-800 Reduced 0.6%	132,705 $10.7 Million
Q1 2024 May 07, 2024	SELL	$69.39 - $97.64 $688,279 - $968,491	-9,919 Reduced 6.92%	133,505 $10.7 Million
Q4 2023 Feb 09, 2024	BUY	$57.42 - $83.61 $267,175 - $389,037	4,653 Added 3.35%	143,424 $11.4 Million
Q3 2023 Nov 03, 2023	SELL	$69.25 - $82.21 $66,549 - $79,003	-961 Reduced 0.69%	138,771 $9.7 Million
Q2 2023 Aug 09, 2023	BUY	$58.41 - $90.35 $247,716 - $383,174	4,241 Added 3.13%	139,732 $10 Million
Q1 2023 May 09, 2023	SELL	$58.39 - $75.0 $192,745 - $247,575	-3,301 Reduced 2.38%	135,491 $8.36 Million
Q4 2022 Feb 13, 2023	SELL	$39.94 - $79.72 $463,863 - $925,868	-11,614 Reduced 7.72%	138,792 $10.7 Million
Q3 2022 Oct 27, 2022	SELL	$36.06 - $69.85 $4.06 Million - $7.86 Million	-112,476 Reduced 42.79%	150,406 $6.71 Million
Q2 2022 Aug 01, 2022	BUY	$21.74 - $46.75 $5.67 Million - $12.2 Million	260,944 Added 13464.6%	262,882 $10.1 Million
Q1 2022 May 11, 2022	SELL	$23.7 - $41.39 $211,830 - $369,943	-8,938 Reduced 82.18%	1,938 $80,000
Q4 2021 Feb 11, 2022	SELL	$30.7 - $43.36 $6,876 - $9,712	-224 Reduced 2.02%	10,876 $411,000
Q3 2021 Nov 10, 2021	BUY	$19.91 - $68.26 $31,656 - $108,533	1,590 Added 16.72%	11,100 $366,000
Q2 2021 Aug 05, 2021	BUY	$50.63 - $73.5 $6,885 - $9,996	136 Added 1.45%	9,510 $641,000
Q1 2021 Apr 28, 2021	BUY	$55.91 - $81.44 $17,499 - $25,490	313 Added 3.45%	9,374 $531,000
Q4 2020 Feb 04, 2021	BUY	$66.31 - $86.52 $41,775 - $54,507	630 Added 7.47%	9,061 $738,000
Q3 2020 Nov 10, 2020	BUY	$68.34 - $85.84 $388,034 - $487,399	5,678 Added 206.25%	8,431 $601,000
Q2 2020 Aug 07, 2020	SELL	$49.87 - $98.69 $17,504 - $34,640	-351 Reduced 11.31%	2,753 $226,000
Q1 2020 May 13, 2020	BUY	$41.2 - $101.31 $51,829 - $127,447	1,258 Added 68.15%	3,104 $183,000
Q4 2019 Feb 04, 2020	BUY	$16.71 - $106.24 $10,911 - $69,374	653 Added 54.74%	1,846 $191,000
Q3 2019 Nov 08, 2019	BUY	$20.24 - $29.16 $7,509 - $10,818	371 Added 45.13%	1,193 $25,000
Q2 2019 Aug 13, 2019	BUY	$13.46 - $25.75 $11,064 - $21,166	822 New	822 $21,000

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account